American Delirium Society 2022 Year in Review: Highlighting the Year's Most Impactful Delirium Research.
American Delirium Society 2022 Year in Review: Highlighting the Year's Most Impactful Delirium Research.
复制标题
DOI：
10.56392/001c.73356
复制
发表时间：
2023-03
期刊：
影响因子：
--
通讯作者：
C. A. Austin;B. Palanca;Kendall Smith;Benjamin Chapin;Shih-Yin Lin;S. Khan;H. Lindroth;Kerri Maya;Mark A. Oldham
中科院分区：
文献类型：
--
作者：
C. A. Austin;B. Palanca;Kendall Smith;Benjamin Chapin;Shih-Yin Lin;S. Khan;H. Lindroth;Kerri Maya;Mark A. Oldham
背景自2015年以来，美国妄想症协会(ADS)研究委员会对妄想症文献进行了年度调查，以便在其年度回顾会议上提交。我们的目标是描述2021-2022年使用的审查过程，并总结选定的出版物。方法ADS研究委员会每位成员提名6篇被认为是从2021年9月1日至2022年7月31日发表的最具影响力的原发精神分裂症研究论文。24项提名研究按文章数量分为三类：医疗干预试验、非医疗干预试验和精神错乱检测/基础科学研究。ADS研究委员会的每个成员在其分配的类别中对所有研究进行了方法严谨和影响方面的排名，每项研究的评分为0-10，总分为0-20。事先决定在每个类别中选出得分最高的三篇文章进行展示，平局由委员会协商一致决定。结果19名研究委员会成员担任评审员。每个类别的得分相似：医疗干预平均(标准差)12.8(1.1)，非医疗干预13.1(1.1)，检测/基础科学12.6(1.0)。我们总结了在2022年ADS年度审查会议上提交的论文的结果。结论：在2022年ADS年度回顾会议上提出的研究的多样性表明了精神错乱领域的广度和临床试验的不断增加。出版物在一系列广泛、多样的期刊上的传播进一步证明了需要专门针对精神错乱的期刊。
Background Since 2015, the American Delirium Society (ADS) Research Committee has conducted an annual survey of the delirium literature for presentation in its year-in-review session. Our objectives were to describe the review process used for the 2021-2022 and to summarise the selected publications. Methods Each member of the ADS Research Committee nominated up to 6 publications considered to be the most impactful primary delirium research published from September 1, 2021, to July 31, 2022. The 24 nominated studies were divided into three categories balanced by number of articles: medical intervention trials, non-medical intervention trials, and delirium detection/basic science studies. Each ADS Research Committee member ranked all studies in their assigned category for methodological rigor and for impact, each being scored as 0-10, for a total score of 0-20. It was decided a priori to select the top three highest-scoring articles in each category for presentation, with ties adjudicated by Committee consensus. Results Nineteen Research Committee members served as reviewers. Scores for each category were similar: medical interventions mean (standard deviation) 12.8 (1.1), non-medical interventions 13.1 (1.1), and detection/basic science 12.6 (1.0). We summarise the results of the papers presented in the 2022 ADS year-in-review session. Conclusion The diversity of studies presented for the 2022 ADS year-in-review session illustrates the breadth of the delirium field and the growing number of clinical trials. The dissemination of publications across a broad, diverse array of journals provides further justification of the need for delirium-specific journals.